| 10th Annual Event Takes Place in Vancouver British Columbia Feb 26-28 2012 SEATTLE, Feb. 27, 2012 (GLOBE NEWSWIRE) -- TapImmune Inc. (OTCBB:TPIV), a vaccine technologies company specializing in the development of innovative immunotherapeutics and vaccines in the areas of oncology and infectious disease, is pleased to announce that Dr. Glynn Wilson, Chief Executive Officer, will be presenting at the 10th Annual BioPartnering North America (BPN) in Vancouver, BC, Canada, February 26-28, 2012. Parti...continued TPIV |
SmallCapUpdates provides the latest news and alerts on stocks for you. If you are looking for the latest on stocks in clean energy, medical innovation, mining, biotech, nanotech, renewable energy, internet technology or in emerging markets.
Pages
▼
No comments:
Post a Comment